A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio

被引:9
作者
Fan, Ningbo [1 ]
Chen, Dongni [1 ]
Zheng, Jiabo [2 ]
Wen, Zhesheng [1 ]
Lin, Peng [1 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, Dept Thorac Oncol, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Gastrointestinal Surg, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China
来源
CANCER MANAGEMENT AND RESEARCH | 2019年 / 11卷
关键词
esophageal squamous cell carcinoma; prognostic indicator; fibrinogen; lymphocyte; GROWTH-FACTORS; CANCER; LYMPHOPENIA; MECHANISMS; SURVIVAL; MARKER;
D O I
10.2147/CMAR.S204938
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. Patients and methods: We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan-Meier estimator and compared using the log-rank test. Results: The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (<= 3.03) group, the FLR-high (>3.03) group included older patients (chi(2)=7.267, P=0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%,chi(2)=5.414, P=0.020) and tended to die within one year (23.5% vs 10.9%,chi(2)=10.871, P=0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, P=0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, P=0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95% CI: 1.073-1.952, P=0.015), DFS (HR: 1.445, 95% CI: 1.084-1.925, P=0.012) and first-year mortality (HR: 2.123, 95% CI: 1.157-3.898, P=0.015). Conclusion: The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy.
引用
收藏
页码:4719 / 4728
页数:10
相关论文
共 31 条
[1]   Analysis of the Fibrinogen and Neutrophil-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma A Promising Blood Marker of Tumor Progression and Prognosis [J].
Arigami, Takaaki ;
Okumura, Hiroshi ;
Matsumoto, Masataka ;
Uchikado, Yasuto ;
Uenosono, Yoshikazu ;
Kita, Yoshiaki ;
Owaki, Tetsuhiro ;
Mori, Shinichiro ;
Kurahara, Hiroshi ;
Kijima, Yuko ;
Ishigami, Sumiya ;
Natsugoe, Shoji .
MEDICINE, 2015, 94 (42) :e1702
[2]   X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization [J].
Camp, RL ;
Dolled-Filhart, M ;
Rimm, DL .
CLINICAL CANCER RESEARCH, 2004, 10 (21) :7252-7259
[3]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[4]   Fibrinogen as a key regulator of inflammation in disease [J].
Davalos, Dimitrios ;
Akassoglou, Katerina .
SEMINARS IN IMMUNOPATHOLOGY, 2012, 34 (01) :43-62
[5]   Immune Therapy for Cancer [J].
Dougan, Michael ;
Dranoff, Glenn .
ANNUAL REVIEW OF IMMUNOLOGY, 2009, 27 :83-117
[6]   Coagulation and cancer: biological and clinical aspects [J].
Falanga, A. ;
Marchetti, M. ;
Vignoli, A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (02) :223-233
[7]   Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer [J].
Falanga, Anna ;
Schieppati, Francesca ;
Russo, Domenico .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (07) :756-764
[8]   Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Dikshit, Rajesh ;
Eser, Sultan ;
Mathers, Colin ;
Rebelo, Marise ;
Parkin, Donald Maxwell ;
Forman, David ;
Bray, Freddie .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386
[9]   Immunity, Inflammation, and Cancer [J].
Grivennikov, Sergei I. ;
Greten, Florian R. ;
Karin, Michael .
CELL, 2010, 140 (06) :883-899
[10]   Novel Aspects of Fibrin(ogen) Fragments during Inflammation [J].
Jennewein, Carla ;
Nguyen Tran ;
Paulus, Patrick ;
Ellinghaus, Peter ;
Eble, Johannes Andreas ;
Zacharowski, Kai .
MOLECULAR MEDICINE, 2011, 17 (5-6) :568-573